Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

EMA grants positive opinion for teriparatide biosimilar

Nov. 17, 2016

Novel optimized mouse model of cyclophosphamide-induced bone marrow suppression

Nov. 16, 2016

Resunab demonstrates clinical benefit in phase II trial in systemic sclerosis

Nov. 16, 2016

FDA awards orphan drug designation to ECCS-50 for scleroderma

Nov. 15, 2016

Medshine Discovery presents JAK2 inhibitors

Nov. 14, 2016

Mabion signs development and commercialization agreement with Mylan for Mabion-CD20

Nov. 10, 2016

ReVance Therapeutics initiates phase II trial of RT-002 in plantar fasciitis

Nov. 4, 2016

Mitsubishi Tanabe and Kolon Life Science sign licensing agreement for Invossa in Japan

Nov. 2, 2016

Flexion Therapeutics reports positive results from study of Zilretta in OA patients with diabetes

Nov. 2, 2016

AbbVie discloses TNF-alpha modulators

Nov. 2, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...